Nektar Therapeutics (NKTR)
90.21
-1.47
(-1.60%)
USD |
NASDAQ |
Apr 27, 12:28
Nektar Therapeutics Profit Margin (Quarterly) : -165.4% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp. | 25.74% |
| Eli Lilly & Co. | 34.40% |
| Soleno Therapeutics, Inc. | 46.81% |
| Aquestive Therapeutics, Inc. | -244.8% |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -364.3% |
| Return on Assets | -60.80% |
| Return on Invested Capital | -74.65% |
| Gross Profit Margin (Quarterly) | 99.13% |
| Operating Margin (Quarterly) | -87.54% |
| Return on Net Operating Assets | -816.4% |